The entire country is troubled by the second wave of Corona. Weeds have spread from city to village. Not knowing how many lives were lost due to lack of oxygen, because information is not available even in the government records. Among all these, vaccination is said to be the biggest weapon in the fight against Corona.
There are three vaccines in India these days. Kovicin of India Biotech, Kovishield of Serum Institute and Sputnik V Vaccine of Russia. In the midst of all this, work is also being done on the vaccine given by the nose. It is believed that this vaccine will prove to be the biggest weapon in the war with Corona.
How many vaccines are being worked on
The World Health Organization (WHO) has recently informed that work is being done on 7 intronasal vaccines all over the world. Their clinical trials are continuing in the US, UK, India and China.
What are the benefits of nasal spray vaccine
Nasal spray vaccine means that the vaccine given by the nose is considered more effective. Experts are claiming that it can be a game changer. In this, the need for syringes will be eliminated, so that there will be no risk of injury and infection. It can also bring better options for children.
100 million doses by December
NITI Aayog member VK Paul says that Bharat Biotech can bring 100 million doses of its nasal vaccine by December this year. The clinical trial for the vaccine is in progress.
What to say about Bharat Biotech
Bharat Biotech, the manufacturer of covacine, says that their nasal vaccine will respond immediately through our immune system upon the entry of the BBV154 virus. This will reduce the risk of infection significantly. This will work for children and adults.
Serum Institute’s single dose vaccine
American company Kodagenics is developing an intranasal vaccine COVI-VAC in association with Serum Institute of India. This is a single dose vaccine. The clinical trial of its first phase continues. It is effective against all strains of COVID. It is claimed that this vaccine will get the longest cellular immunity.
American company Altimeune’s vaccine
AltEmune is making a vaccine under the name of Adcovid. It will be given through the nose. Its clinical trial is going on. The results of the trial may come up till the second quarter of 2021. The company says that the virus makes a repository in the nose, in which case the vaccine given by the nose will be more effective.
The nasal vaccine of Finland
A vaccine is also underway in Finland’s Rokote Lab. It will be an intranasal vaccine.
Canadian Company’s Nasal Spray
Canadian company Sanotize has developed a nasal spray. Clinical trials of two phases have also taken place. According to some reports, the company is looking for a partner for entry into India.